Answers are grounded in this paper and cite their sources.
Isothermal nucleic acid amplification can reduce instrumentation requirements for viral testing, but faster reactions with purified targets do not necessarily produce reliable results from primary specimens. This critical narrative review examines selected human and veterinary virus-directed studies; nonviral investigations supply mechanistic context, not estimates of viral diagnostic performance. We compare evidence for target recovery, ribonucleic acid (RNA) conversion, recognition, amplification, reporting, device integration, and interpretation while separating analytical, contrived-matrix, and authentic-specimen endpoints. Differences in inputs, probability-based detection limits, comparator populations, and timing boundaries prevent simple platform rankings. We propose matched, stage-resolved measurements and tube-to-device comparisons to test candidate causes of lost performance. Four complementary evaluation domains—analytical feasibility, specimen-matrix and sequence effects, integrated-system robustness, and intended-use performance—organize this evidence without imposing a mandatory validation sequence. The domain mapping and causal decision rules are methodological proposals, not prospectively validated diagnostic or regulatory pathways. Their purpose is to guide testable comparisons of whether component-level gains improve a prespecified specimen-level outcome.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: